510(k) Report

510(k) · Cleared

Cleared

EZE SIT Valvulotome

K190267510(k) TraditionalCleared Oct 30, 2019264-day reviewClass II21 CFR 870.4885

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lemaitre Vascular · MGZ Valvulotome

Cleared on Oct 30, 2019 as substantially equivalent to K930011 (Uresil Corp., 1993) after a 264-day review. Its family tree reaches back 1 generation to 1993.

Decided
Oct 30, 2019
Review
264 days
Class
Class II
Product code
MGZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K930011 (1993). No later device cites it as a predicate yet.

K930011 · Uresil Valve Cutter with Interchangeable Heads · Uresil Corp. · 19931990199520002005201020152020
  1. Root · 1 generation backK930011 Uresil Valve Cutter with Interchangeable HeadsUresil Corp. · 1993
  2. This deviceK190267 EZE SIT ValvulotomeLemaitre Vascular · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K930011Uresil Valve Cutter with Interchangeable HeadsUresil Corp.1993—
0 (this device)K190267EZE SIT ValvulotomeLemaitre Vascular2019—
FIG. 1 — Lineage of K190267, 1993–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MGZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MGZ device

  1. #1 K260188 LimFlow Vectorscore 11.9 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K930011Uresil Valve Cutter with Interchangeable Heads
Summary page 4
…o prior submissions have been made for the changes detailed in this traditional 510(k). II. PREDICATE DEVICE Tru-Incise Valvulotome (K930011) This predicate device has not been subject to a design- related recall…
Uresil Corp.1993—

Also cleared against K930011: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K930011.

How does its category compare?

All MGZ devices

MGZ Valvulotome: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · MGZ

1in 2025

2008: 12011: 12013: 22014: 22019: 12022: 12025: 12026 (partial year): 1
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MGZ

Too few MGZ 510(k)s in any year since 2007 to give a median.

Recalls per year · MGZ

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MGZ

8in 2025

2007: 22009: 32014: 12016: 32017: 212018: 72019: 192020: 62021: 22022: 132023: 232024: 32025: 8
2007high 23 (2023) · low 0 (2008)2025

MAUDE reports naming product code MGZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—00
20090—03
20100—00
20111—00
20120—00
20132—00
20142—11
20150—00
20160—03
20170—021
20180—07
20191—019
20200—06
20210—02
20221—013
20230—023
20240—03
20251—08
20261—0—

What is it indicated for?

The EZE SIT Valvulotome is intended to render venous valves incompetent during in situ bypass procedures. This includes distal infrainguinal bypass when a non-anatomic position is required (e.g., profunda to anterior tibial artery), composite vein infrainguinal bypass, or aorto-renal bypass procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K190267: EZE SIT Valvulotome.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K190267

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026